Preclinical molecular imaging
The Preclinical Molecular Imaging Facility comprises some of the most advanced imaging technologies, a state-of-the-art radiochemistry laboratory and Australia’s only cyclotron dedicated to medical research. It is a research platform and node of the National Imaging Facility and therefore available to genuine researchers for shared, collaborative research projects.
The combined research and infrastructure, and complementary expertise of the two partners: the University of Sydney’s Brain and Mind Research Institute and Australian Nuclear Science and Technology Organisation (ANSTO) LifeSciences are what makes this facility unique.
The facility enables technology-driven, interdisciplinary research and development in molecular imaging technology and its applications. Research is focussed on health issues of national and international importance, such as cancer, dementia and psychoses.
The main research activity is the development of novel biomarkers and non-invasive imaging techniques that can be used to improve our understanding of disease, and lead to better diagnosis and treatment of debilitating illnesses, with a special focus on neurological conditions.
- 18 MeV cyclotron producing fluorine-18 and carbon-11
- Inveon PET/SPECT/CT scanner
- Inveon PET/CT scanner
- Focus 220 PET scanner
- Phosphor imager
- Gamma counter
- Blade server
- Attached storage
- Data repository and backup